| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |